Guidelines International Network | Guidelines International Network (GIN)

Clinical practice guidelines for keratinocyte cancer

MeSH Terms: Early Detection of Cancer (E01.390.500); Colonoscopy (E04.210.240.250.160); Australia (Z01.639.100)
Guideline Contact: [email protected]
Date for Review: 2007-12-23
Publication Scope: screening; treatment
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: Cancer Council Australia (AU)
Publication Year: 2018
Name of Endorsing Organization: National Health & Medical Research Council

MeSH Terms: Glioma; Epilepsy; Humans; Diagnosis; Therapy; Neurosurgical Procedures; Anticonvulsants
Guideline Contact: Xing Fan ([email protected]); Suhui Kuang ([email protected])
English Title Translation: Clinical Practice Guidelines for The Diagnosis and Treatment of Diffuse Glioma-Related Epilepsy: 2025 update
Keywords: Diffuse glioma; Epilepsy; Clinical pratice guideslines; Diagnosis; Treatment; Surgery; Anti-seizure Medications
Expected Publication Date: 2026
Date of Last Evidence Search: 14/11/2025
Methods Applied: Evidence synthesis; Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence; Delphi method; GRADE
Publication Scope: Diagnosis, Treatment, Management
Countries of Application: Worldwide
Guideline Publication Status: Submitted
Languages: English
Authors: The China Association Against Epilepsy; The Society for Neuro-Oncology of China
Willingness to Collaborate: Yes
Name of Endorsing Organization: The China Association Against Epilepsy; The Society for Neuro-Oncology of China

MeSH Terms: Colorectal Neoplasms (C04.588.274.476.411.307); Early Detection of Cancer (E01.390.500); Australia (Z01.639.100)
Guideline Contact: [email protected]
Date for Review: 2027-10-22
Publication Scope: diagnosis; management; prevention; screening
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: Cancer Council Australia (AU)
Publication Year: 2017
Name of Endorsing Organization: National Health & Medical Research Council

MeSH Terms: Factor XI Deficiency (C15.378.100.100.325); Factor X Deficiency (C15.378.100.100.320); Factor VII Deficiency (C15.378.100.100.310); Factor V Deficiency (C15.378.100.100.300); von Willebrand Diseases (C15.378.100.100.900); Blood Coagulation Disorders; Inherited (C15.378.100.100); Hemophilia B (C15.378.100.100.510); Hemophilia A (C15.378.100.100.500); Factor XIII Deficiency (C15.378.100.100.335); Factor XII Deficiency (C15.378.100.100.330)
Guideline Contact: Skye Newton ([email protected])
Publication Scope: management
Countries of Application: Australia
Guideline Publication Status: Published
Languages: English
Authors: AHTA (AU)
Publication Year: 2005

MeSH Terms
Guideline Contact: Nafsin Nizum ([email protected])
Publication Date: 2024
Methods Applied: Systematic review, GRADE approach
Countries of Application: Asia-Pacific countries; Australia; Belgium; Canada; China; Denmark; Egypt; Europe; Finland; France; Germany; India; International; Italy; Japan; Kingdom of Saudi Arabia; Korea; Latin America; Malaysia; Netherlands; New Zealand; Qatar; Scotland; Singapore; South Africa; Spain; Tunisia; United Kingdom; United Kingdom; United States
Guideline Publication Status: Published
Languages: English
Authors: RNAO (CA)
Publication Year: 2024

Links

MeSH Terms: breast cancer, neoplasm, carcinoma, malignancy, tumor, oncotype, prosigna, PAM50, mammaprint, 70 gene, endopredict, breast cancer index, BCI, tailorx, rxponder, swog, swog S1007, swog S8814, nsabp, nsabp b20, nsabp b-20, nsabp b 20, nsabp b14, nsabp b-14, nsabp b 14, transatac, ma17, ma 17, ma-17, ma12, ma 12, ma-12, ABCSG-6, ABCSG 6, ABCSG-8, ABCSG 8, mindact, raster adj2 study, geicam 9906, geicam-9906, geicam9906, OPTIMA adj2 study, 21 gene, recurrence score
Guideline Contact: Duvaraga Sivajohanathan; [email protected]
Keywords: breast cancer, oncotype dx, prosigna, mammaprint, endopredict, breast cancer index
Date for Review: In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date: 2022-01-28
Date of Last Evidence Search: 2021-12-15
Methods Applied: Systematic review-based, Externally reviewed, Evidence quality assessment, Patient/survivors/caregivers participation
Publication Scope: Guidelines; prognosis; treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: PEBC (Program in evidenced-based care)
Publication Year: 2022

MeSH Terms: Deoxyglucose (D09.254.229); Sarcoidosis (C15.604.515.827); Tomography; Emission-Computed (E01.370.350.350.800)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: assessment; management
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2011

MeSH Terms: Prostatic Neoplasms (C04.588.945.440.770); Cryotherapy (E02.258); Cryosurgery (E04.014.180); Prostatectomy (E04.950.774.860.625); Radiotherapy (E02.815); Brachytherapy (E02.815.150); Watchful Waiting (N04.761.559.590.900)
Guideline Contact: [email protected]
Publication Date: 05-Sep-18
Publication Scope: management
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2018

MeSH Terms: Anti-Infective Agents [D27.505.954.122] Clostridioides difficile [B03.353.625.657.500] Clostridium Infections [C01.150.252.410.222] Drug Resistance, Microbial [G07.690.773.984.269]
Publication Scope: management; treatment
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2021